close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Wave Life Sciences Ltd. - Ordinary Shares (NQ:WVE)

8.890 +0.590 (+7.11%)
Streaming Delayed Price Updated: 2:38 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Wave Life Sciences Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 Next >
Keep an eye on the top gainers and losers in Wednesday's session.
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Deep Dive Into WAVE Life Sciences Stock: Analyst Perspectives (6 Ratings)
 
Via Benzinga
Peering Into WAVE Life Sciences's Recent Short Interest
 
Via Benzinga
Top movers analysis one hour before the close of the markets on 2025-09-03: top gainers and losers in today's session.
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
Wave Life Sciences Tumbled 19% Today, But Not Everyone’s Disappointed – Find Out Why
Via Stocktwits
Forecasting The Future: 7 Analyst Projections For WAVE Life Sciences
 
Via Benzinga
Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday?
Wave Life Sciences shares early WVE-006 trial results in alpha-1 antitrypsin deficiency, reporting durable protein production and favorable safety. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Crude Oil Falls Over 2%; Campbell's Earnings Top Estimates
 
Via Benzinga
Wednesday's session: gap up and gap down stocks
Today's session on Wednesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
Via Chartmill
Earnings Scheduled For July 30, 2025
 
Via Benzinga
Insights into WAVE Life Sciences's Upcoming Earnings
 
Via Benzinga
Nasdaq Gains Over 100 Points; Dollar Tree Post Upbeat Earnings
 
Via Benzinga
Which stocks are moving before the opening bell on Wednesday?
Wondering what's happening in Wednesday's pre-market session? Find an overview in this article. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
 
Via Benzinga
Earnings Scheduled For May 8, 2025
 
Via Benzinga
WAVE Life Sciences Earnings Preview
 
Via Benzinga
Beyond The Numbers: 6 Analysts Discuss WAVE Life Sciences Stock
 
Via Benzinga
Wave (WVE) Q2 Revenue Drops 56%
Via The Motley Fool
Wave Life Sciences Ltd (NASDAQ:WVE) Reports Q2 2025 Earnings: Revenue Miss but Narrower Loss and Clinical Progress Boost Shares
Wave Life Sciences Q2 2025 results show $8.7M revenue miss but narrower EPS loss. Stock rises on optimism for WVE-006's AATD clinical progress. 
Via Chartmill
This MongoDB Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
 
Via Benzinga
Breaking Down WAVE Life Sciences: 4 Analysts Share Their Views
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Where WAVE Life Sciences Stands With Analysts
 
Via Benzinga
The Analyst Verdict: WAVE Life Sciences In The Eyes Of 4 Experts
 
Via Benzinga
Wave Life Sciences Stock Jumps On Positive Data From Muscle Disorder Drug, Plans FDA Submission Next Year
Wave Life plans a 2026 NDA filing for WVE-N531 after positive Phase 2 data in Duchenne muscular dystrophy, showing functional gains and biomarker improvements. 
Via Benzinga
This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
 
Via Benzinga
Earnings Scheduled For March 4, 2025
 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today